Emerging regulatory paradigms in glutathione metabolism

Advances in Cancer Research

Volumn 122, Issue , 2014, Pages 69-101

  Liu, Yilin ^a   Hyde, Annastasia S ^a   Simpson, Melanie A ^a   Barycki, Joseph J ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

5 Oxoprolinase; ChaC1; Glutamate cysteine ligase; Glutathione; Glutathione synthetase; Redox homeostasis; Glutamyl cycle; Glutamylcyclotransferase; Glutamyltranspeptidase

Indexed keywords

4 HYDROXYNONENAL; 5 OXOPROLINASE; CASPASE 3; CHAC1 PROTEIN; CYSTEINE; GAMMA GLUTAMYLCYCLOTRANSFERASE; GAMMA GLUTAMYLCYSTEINE; GAMMA GLUTAMYLTRANSFERASE; GLUTAMATE CYSTEINE LIGASE; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLUTATHIONE SYNTHASE; GLYCINE; LIPID; PROTEIN; PYROGLUTAMIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; BUFFER;

AMINO ACID TRANSPORT; APOPTOSIS; ARTICLE; BIOAVAILABILITY; BIOSYNTHESIS; CANCER CELL LINE; CANCER GROWTH; CANCER STEM CELL; CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY; CELL FUNCTION; CELL MEMBRANE; COMPLEX FORMATION; DETOXIFICATION; EMBRYO DEVELOPMENT; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME MECHANISM; GENE REGULATORY NETWORK; GLUTATHIONE METABOLISM; GLYCATION; GLYCOLYSIS; HUMAN; LIPID PEROXIDATION; METABOLIC BALANCE; MUTATIONAL ANALYSIS; NEGATIVE FEEDBACK; NEOPLASM; NONHUMAN; ONCOGENE C MYC; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; ANIMAL; CHEMISTRY; DISEASE COURSE; GENE EXPRESSION REGULATION; HOMEOSTASIS; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; BUFFERS; DISEASE PROGRESSION; GAMMA-GLUTAMYLCYCLOTRANSFERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; GLUTATHIONE SYNTHASE; HOMEOSTASIS; HUMANS; LIPIDS; MICE; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHORYLATION; PYROGLUTAMATE HYDROLASE;

EID: 84902984780     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-420117-0.00002-5     Document Type: Chapter

References (147)

1. Andringa K.K., Coleman M.C., Aykin-Burns N., Hitchler M.J., Walsh S.A., Domann F.E., et al. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose. Cancer Research 2006, 66:1605-1610.
2. Bachhawat A.K., Thakur A., Kaur J., Zulkifli M. Glutathione transporters. Biochimica et Biophysica Acta 2013, 1830:3154-3164.
3. Backos D.S., Fritz K.S., McArthur D.G., Kepa J.K., Donson A.M., Petersen D.R., et al. Glycation of glutamate cysteine ligase by 2-deoxy-d-ribose and its potential impact on chemoresistance in glioblastoma. Neurochemical Research 2013, 38:1838-1849.
4. Backos D.S., Fritz K.S., Roede J.R., Petersen D.R., Franklin C.C. Posttranslational modification and regulation of glutamate-cysteine ligase by the alpha, beta-unsaturated aldehyde 4-hydroxy-2-nonenal. Free Radical Biology & Medicine 2011, 50:14-26.
5. Biterova E.I., Barycki J.J. Mechanistic details of glutathione biosynthesis revealed by crystal structures of Saccharomyces cerevisiae glutamate cysteine ligase. The Journal of Biological Chemistry 2009, 284:32700-32708.
6. Boanca G., Sand A., Barycki J.J. Uncoupling the enzymatic and autoprocessing activities of Helicobacter pylori gamma-glutamyltranspeptidase. The Journal of Biological Chemistry 2006, 281:19029-19037.
7. Boanca G., Sand A., Okada T., Suzuki H., Kumagai H., Fukuyama K., et al. Autoprocessing of Helicobacter pylori gamma-glutamyltranspeptidase leads to the formation of a threonine-threonine catalytic dyad. The Journal of Biological Chemistry 2007, 282:534-541.
8. Board P.G., Moore K.A., Smith J.E. Purification and properties of gamma-glutamylcyclotransferase from human erythrocytes. The Biochemical Journal 1978, 173:427-431.
9. Brigelius-Flohe R., Maiorino M. Glutathione peroxidases. Biochimica et Biophysica Acta 2013, 1830:3289-3303.
10. Brown T.R., Drummond M.L., Barelier S., Crutchfield A.S., Dinescu A., Slavens K.D., et al. Aspartate 458 of human glutathione synthetase is important for cooperativity and active site structure. Biochemical and Biophysical Research Communications 2011, 411:536-542.
11. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nature Reviews Cancer 2011, 11:85-95.
12. Calpena E., Casado M., Martinez-Rubio D., Nascimento A., Colomer J., Gargallo E., et al. 5-Oxoprolinuria in heterozygous patients for 5-oxoprolinase (OPLAH) missense changes. JIMD Reports 2013, 7:123-128.
13. Carter B.Z., Shi Z.Z., Barrios R., Lieberman M.W. Gamma-glutamyl leukotrienase, a gamma-glutamyl transpeptidase gene family member, is expressed primarily in spleen. The Journal of Biological Chemistry 1998, 273:28277-28285.
14. Castonguay R., Lherbet C., Keillor J.W. Kinetic studies of rat kidney gamma-glutamyltranspeptidase deacylation reveal a general base-catalyzed mechanism. Biochemistry 2003, 42:11504-11513.
15. Chen X., Schecter R.L., Griffith O.W., Hayward M.A., Alpert L.C., Batist G. Characterization of 5-oxo-L-prolinase in normal and tumor tissues of humans and rats: A potential new target for biochemical modulation of glutathione. Clinical Cancer Research 1998, 4:131-138.
16. Chen Y., Shertzer H.G., Schneider S.N., Nebert D.W., Dalton T.P. Glutamate cysteine ligase catalysis: Dependence on ATP and modifier subunit for regulation of tissue glutathione levels. The Journal of Biological Chemistry 2005, 280:33766-33774.
17. Chen Y., Yang Y., Miller M.L., Shen D., Shertzer H.G., Stringer K.F., et al. Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure. Hepatology 2007, 45:1118-1128.
18. Chien J., Fan J.B., Bell D.A., April C., Klotzle B., Ota T., et al. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecologic Oncology 2009, 114:3-11.
19. Currais A., Maher P. Functional consequences of age-dependent changes in glutathione status in the brain. Antioxidants and Redox Signaling 2013, 19:813-822.
20. Dahl N., Pigg M., Ristoff E., Gali R., Carlsson B., Mannervik B., et al. Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Human Molecular Genetics 1997, 6:1147-1152.
21. Dalton T.P., Dieter M.Z., Yang Y., Shertzer H.G., Nebert D.W. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: Embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous. Biochemical and Biophysical Research Communications 2000, 279:324-329.
22. Daye D., Wellen K.E. Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis. Seminars in Cell & Developmental Biology 2012, 23:362-369.
23. DeBerardinis R.J., Mancuso A., Daikhin E., Nissim I., Yudkoff M., Wehrli S., et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:19345-19350.
24. Dickinson D.A., Forman H.J. Glutathione in defense and signaling: Lessons from a small thiol. Annals of the New York Academy of Sciences 2002, 973:488-504.
25. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., Kulp A.N., et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783.
26. Dinescu A., Brown T.R., Barelier S., Cundari T.R., Anderson M.E. The role of the glycine triad in human glutathione synthetase. Biochemical and Biophysical Research Communications 2010, 400:511-516.
27. Dinescu A., Cundari T.R., Bhansali V.S., Luo J.L., Anderson M.E. Function of conserved residues of human glutathione synthetase: Implications for the ATP-grasp enzymes. The Journal of Biological Chemistry 2004, 279:22412-22421.
28. Doulias P.T., Tenopoulou M., Greene J.L., Raju K., Ischiropoulos H. Nitric oxide regulates mitochondrial fatty acid metabolism through reversible protein S-nitrosylation. Science Signaling 2013, 6:rs1.
29. Fan X., Liu X., Hao S., Wang B., Robinson M.L., Monnier V.M. The LEGSKO mouse: A mouse model of age-related nuclear cataract based on genetic suppression of lens glutathione synthesis. PLoS One 2012, 7:e50832.
30. Fawaz M.V., Topper M.E., Firestine S.M. The ATP-grasp enzymes. Bioorganic Chemistry 2011, 39:185-191.
31. Franklin C.C., Backos D.S., Mohar I., White C.C., Forman H.J., Kavanagh T.J. Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Molecular Aspects of Medicine 2009, 30:86-98.
32. Franklin C.C., Krejsa C.M., Pierce R.H., White C.C., Fausto N., Kavanagh T.J. Caspase-3-dependent cleavage of the glutamate-L-cysteine ligase catalytic subunit during apoptotic cell death. The American Journal of Pathology 2002, 160:1887-1894.
33. Fraser J.A., Kansagra P., Kotecki C., Saunders R.D., McLellan L.I. The modifier subunit of Drosophila glutamate-cysteine ligase regulates catalytic activity by covalent and noncovalent interactions and influences glutathione homeostasis in vivo. The Journal of Biological Chemistry 2003, 278:46369-46377.
34. Frey I.M., Rubio-Aliaga I., Siewert A., Sailer D., Drobyshev A., Beckers J., et al. Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/- mice. Physiological Genomics 2007, 28:301-310.
35. Friesen R.W., Novak E.M., Hasman D., Innis S.M. Relationship of dimethylglycine, choline, and betaine with oxoproline in plasma of pregnant women and their newborn infants. The Journal of Nutrition 2007, 137:2641-2646.
36. Gamcsik M.P., Kasibhatla M.S., Teeter S.D., Colvin O.M. Glutathione levels in human tumors. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals 2012, 17:671-691.
37. Gao P., Tchernyshyov I., Chang T.C., Lee Y.S., Kita K., Ochi T., et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 2009, 458:762-765.
38. Goebel G., Berger R., Strasak A.M., Egle D., Muller-Holzner E., Schmidt S., et al. Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patients. British Journal of Cancer 2012, 106:189-198.
39. Gogos A., Shapiro L. Large conformational changes in the catalytic cycle of glutathione synthase. Structure 2002, 10:1669-1676.
40. Griffith O.W., Bridges R.J., Meister A. Evidence that the gamma-glutamyl cycle functions in vivo using intracellular glutathione: Effects of amino acids and selective inhibition of enzymes. Proceedings of the National Academy of Sciences of the United States of America 1978, 75:5405-5408.
41. Griffith O.W., Mulcahy R.T. The enzymes of glutathione synthesis: Gamma-glutamylcysteine synthetase. Advances in Enzymology and Related Areas of Molecular Biology 1999, 73:209-267. xii.
42. Hama S., Arata M., Nakamura I., Kasetani T., Itakura S., Tsuchiya H., et al. Prevention of tumor growth by needle-free jet injection of anti-C7orf24 siRNA. Cancer Gene Therapy 2012, 19:553-557.
43. Hanigan M.H., Gallagher B.C., Townsend D.M., Gabarra V. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 1999, 20:553-559.
44. Hanigan M.H., Ricketts W.A. Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 1993, 32:6302-6306.
45. Harding J.J. Free and protein-bound glutathione in normal and cataractous human lenses. The Biochemical Journal 1970, 117:957-960.
46. Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases. Annual Review of Pharmacology and Toxicology 2005, 45:51-88.
47. Heisterkamp N., Groffen J., Warburton D., Sneddon T.P. The human gamma-glutamyltransferase gene family. Human Genetics 2008, 123:321-332.
48. Huang C.S., Chang L.S., Anderson M.E., Meister A. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. The Journal of Biological Chemistry 1993, 268:19675-19680.
49. Iida T., Kijima H., Urata Y., Goto S., Ihara Y., Oka M., et al. Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins. Cancer Gene Therapy 2001, 8:803-814.
50. Ikeda Y., Taniguchi N. Gene expression of gamma-glutamyltranspeptidase. Methods in Enzymology 2005, 401:408-425.
51. Ishimoto T., Nagano O., Yae T., Tamada M., Motohara T., Oshima H., et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer cell 2011, 19:387-400.
52. Jackson A.A., Persaud C., Meakins T.S., Bundy R. Urinary excretion of 5-L-oxoproline (pyroglutamic acid) is increased in normal adults consuming vegetarian or low protein diets. The Journal of Nutrition 1996, 126:2813-2822.
53. Jain M., Nilsson R., Sharma S., Madhusudhan N., Kitami T., Souza A.L., et al. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012, 336:1040-1044.
54. Jaramillo M.C., Zhang D.D. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes and Development 2013, 27:2179-2191.
55. Joo N.E., Ritchie K., Kamarajan P., Miao D., Kapila Y.L. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Medicine 2012, 1:295-305.
56. Kageyama S., Iwaki H., Inoue H., Isono T., Yuasa T., Nogawa M., et al. A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma. Proteomics Clinical Applications 2007, 1:192-199.
57. Keillor J.W., Castonguay R., Lherbet C. Gamma-glutamyl transpeptidase substrate specificity and catalytic mechanism. Methods in Enzymology 2005, 401:449-467.
58. Kelley L.A., Sternberg M.J. Protein structure prediction on the Web: A case study using the Phyre server. Nature Protocols 2009, 4:363-371.
59. Kim J.-W., Lee G., Moon S.-M., Park M.-J., Hong S.K., Ahn Y.-H., et al. Metabolomic screening and star pattern recognition by urinary amino acid profile analysis from bladder cancer patients. Metabolomics 2010, 6:202-206.
60. Kinlough C.L., Poland P.A., Bruns J.B., Hughey R.P. Gamma-glutamyltranspeptidase: Disulfide bridges, propeptide cleavage, and activation in the endoplasmic reticulum. Methods in Enzymology 2005, 401:426-449.
61. Krejsa C.M., Franklin C.C., White C.C., Ledbetter J.A., Schieven G.L., Kavanagh T.J. Rapid activation of glutamate cysteine ligase following oxidative stress. The Journal of Biological Chemistry 2010, 285:16116-16124.
62. Kumar A., Bachhawat A.K. OXP1/YKL215c encodes an ATP-dependent 5-oxoprolinase in Saccharomyces cerevisiae: Functional characterization, domain structure and identification of actin-like ATP-binding motifs in eukaryotic 5-oxoprolinases. FEMS Yeast Research 2010, 10:394-401.
63. Kumar A., Tikoo S., Maity S., Sengupta S., Sengupta S., Kaur A., et al. Mammalian proapoptotic factor ChaC1 and its homologues function as gamma-glutamyl cyclotransferases acting specifically on glutathione. EMBO Reports 2012, 13:1095-1101.
64. Lam B.K., Penrose J.F., Freeman G.J., Austen K.F. Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:7663-7667.
65. Le A., Lane A.N., Hamaker M., Bose S., Gouw A., Barbi J., et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metabolism 2012, 15:110-121.
66. Lieberman M.W., Wiseman A.L., Shi Z.Z., Carter B.Z., Barrios R., Ou C.N., et al. Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:7923-7926.
67. Lillig C.H., Berndt C., Holmgren A. Glutaredoxin systems. Biochimica et Biophysica Acta 2008, 1780:1304-1317.
68. Lim J., Lawson G.W., Nakamura B.N., Ortiz L., Hur J.A., Kavanagh T.J., et al. Glutathione-deficient mice have increased sensitivity to transplacental benzo[a]pyrene-induced premature ovarian failure and ovarian tumorigenesis. Cancer Research 2013, 73:908-917.
69. Locasale J.W. Serine, glycine and one-carbon units: Cancer metabolism in full circle. Nature Reviews Cancer 2013, 13:572-583.
70. Locasale J.W., Grassian A.R., Melman T., Lyssiotis C.A., Mattaini K.R., Bass A.J., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nature Genetics 2011, 43:869-874.
71. Lu S.C. Regulation of glutathione synthesis. Molecular Aspects of Medicine 2009, 30:42-59.
72. Lu S.C. Glutathione synthesis. Biochimica et Biophysica Acta 2013, 1830:3143-3153.
73. Lu S.C., Kuhlenkamp J., Garcia-Ruiz C., Kaplowitz N. Hormone-mediated down-regulation of hepatic glutathione synthesis in the rat. The Journal of Clinical Investigation 1991, 88:260-269.
74. Lu S.C., Mato J.M. S-adenosylmethionine in liver health, injury, and cancer. Physiological Reviews 2012, 92:1515-1542.
75. Luo J.L., Huang C.S., Babaoglu K., Anderson M.E. Novel kinetics of mammalian glutathione synthetase: Characterization of gamma-glutamyl substrate cooperative binding. Biochemical and Biophysical Research Communications 2000, 275:577-581.
76. Mannervik B. Five decades with glutathione and the GSTome. The Journal of Biological Chemistry 2012, 287:6072-6083.
77. Masuda Y., Maeda S., Watanabe A., Sano Y., Aiuchi T., Nakajo S., et al. A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with geranylgeraniol. Biochemical and Biophysical Research Communications 2006, 346:454-460.
78. Mayatepek E. 5-Oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle. European Journal of Pediatrics 1999, 158:221-225.
79. Meakins T.S., Persaud C., Jackson A.A. Dietary supplementation with L-methionine impairs the utilization of urea-nitrogen and increases 5-L-oxoprolinuria in normal women consuming a low protein diet. The Journal of Nutrition 1998, 128:720-727.
80. Meister A. On the enzymology of amino acid transport. Science 1973, 180:33-39.
81. Meister A. The gamma-glutamyl cycle. Diseases associated with specific enzyme deficiencies. Annals of Internal Medicine 1974, 81:247-253.
82. Meister A., Anderson M.E. Glutathione. Annual Review of Biochemistry 1983, 52:711-760.
83. Metges C.C., Yu Y.M., Cai W., Lu X.M., Wong S., Regan M.M., et al. Oxoproline kinetics and oxoproline urinary excretion during glycine- or sulfur amino acid-free diets in humans. American Journal of Physiology, Endocrinology and Metabolism 2000, 278:E868-E876.
84. Mitsuishi Y., Taguchi K., Kawatani Y., Shibata T., Nukiwa T., Aburatani H., et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer cell 2012, 22:66-79.
85. Mosharov E., Cranford M.R., Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry 2000, 39:13005-13011.
86. Mungrue I.N., Pagnon J., Kohannim O., Gargalovic P.S., Lusis A.J. CHAC1/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-ATF3-CHOP cascade. Journal of Immunology 2009, 182:466-476.
87. Nanjo S., Asada K., Yamashita S., Nakajima T., Nakazawa K., Maekita T., et al. Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection. Gastric Cancer 2012, 15:382-388.
88. Naumov V.A., Generozov E.V., Zaharjevskaya N.B., Matushkina D.S., Larin A.K., Chernyshov S.V., et al. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetic 2013, 8:921-934.
89. Nicklin P., Bergman P., Zhang B., Triantafellow E., Wang H., Nyfeler B., et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009, 136:521-534.
90. Oakley A.J., Coggan M., Board P.G. Identification and characterization of gamma-glutamylamine cyclotransferase, an enzyme responsible for gamma-glutamyl-epsilon-lysine catabolism. The Journal of Biological Chemistry 2010, 285:9642-9648.
91. Oakley A.J., Yamada T., Liu D., Coggan M., Clark A.G., Board P.G. The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase. An essential enzyme in the gamma-glutamyl cycle. The Journal of Biological Chemistry 2008, 283:22031-22042.
92. Ochi T. Hydrogen peroxide increases the activity of gamma-glutamylcysteine synthetase in cultured Chinese hamster V79 cells. Archives of Toxicology 1995, 70:96-103.
93. Ochi T. Menadione causes increases in the level of glutathione and in the activity of gamma-glutamylcysteine synthetase in cultured Chinese hamster V79 cells. Toxicology 1996, 112:45-55.
94. Ohkama-Ohtsu N., Oikawa A., Zhao P., Xiang C., Saito K., Oliver D.J. A gamma-glutamyl transpeptidase-independent pathway of glutathione catabolism to glutamate via 5-oxoproline in Arabidopsis. Plant Physiology 2008, 148:1603-1613.
95. Ohno Y., Hattori A., Ueda M., Kageyama S., Yoshiki T., Kakeya H. Multiple NF-Y-binding CCAAT boxes are essential for transcriptional regulation of the human C7orf24 gene, a novel tumor-associated gene. The FEBS Journal 2011, 278:4088-4099.
96. Oinonen C., Rouvinen J. Structural comparison of Ntn-hydrolases. Protein Science 2000, 9:2329-2337.
97. Okada T., Suzuki H., Wada K., Kumagai H., Fukuyama K. Crystal structures of gamma-glutamyltranspeptidase from Escherichia coli, a key enzyme in glutathione metabolism, and its reaction intermediate. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6471-6476.
98. Okada T., Suzuki H., Wada K., Kumagai H., Fukuyama K. Crystal structure of the gamma-glutamyltranspeptidase precursor protein from Escherichia coli-Structural changes autocatalytic processing and implications for the maturation mechanism. The Journal of Biological Chemistry 2007, 282:2433-2439.
99. Orlowski M., Meister A. The gamma-glutamyl cycle: A possible transport system for amino acids. Proceedings of the National Academy of Sciences of the United States of America 1970, 67:1248-1255.
100. Orlowski M., Meister A. Partial reactions catalyzed by -glutamylcysteine synthetase and evidence for an activated glutamate intermediate. The Journal of Biological Chemistry 1971, 246:7095-7105.
101. Orlowski M., Richman P.G., Meister A. Isolation and properties of gamma-L-glutamylcyclotransferase from human brain. Biochemistry 1969, 8:1048-1055.
102. Palekar A.G., Tate S.S., Meister A. Formation of 5-oxoproline from glutathione in erythrocytes by the gamma-glutamyltranspeptidase-cyclotransferase pathway. Proceedings of the National Academy of Sciences of the United States of America 1974, 71:293-297.
103. Persaud C., Forrester T., Jackson A.A. Urinary excretion of 5-L-oxoproline (pyroglutamic acid) is increased during recovery from severe childhood malnutrition and responds to supplemental glycine. The Journal of Nutrition 1996, 126:2823-2830.
104. Pompella A., Corti A., Paolicchi A., Giommarelli C., Zunino F. Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Current Opinion in Pharmacology 2007, 7:360-366.
105. Quintana-Cabrera R., Bolanos J.P. Glutathione and gamma-glutamylcysteine in the antioxidant and survival functions of mitochondria. Biochemical Society Transactions 2013, 41:106-110.
106. Richman P.G., Meister A. Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione. The Journal of Biological Chemistry 1975, 250:1422-1426.
107. Ristoff E., Larsson A. Inborn errors in the metabolism of glutathione. Orphanet Journal of Rare Diseases 2007, 2:16.
108. Sasaki H., Sato H., Kuriyama-Matsumura K., Sato K., Maebara K., Wang H., et al. Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. The Journal of Biological Chemistry 2002, 277:44765-44771.
109. Sato H., Shiiya A., Kimata M., Maebara K., Tamba M., Sakakura Y., et al. Redox imbalance in cystine/glutamate transporter-deficient mice. The Journal of Biological Chemistry 2005, 280:37423-37429.
110. Seelig G.F., Simondsen R.P., Meister A. Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. The Journal of Biological Chemistry 1984, 259:9345-9347.
111. Sekura R., Meister A. Glutathione turnover in the kidney; considerations relating to the gamma-glutamyl cycle and the transport of amino acids. Proceedings of the National Academy of Sciences of the United States of America 1974, 71:2969-2972.
112. Shi Z.Z., Osei-Frimpong J., Kala G., Kala S.V., Barrios R.J., Habib G.M., et al. Glutathione synthesis is essential for mouse development but not for cell growth in culture. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:5101-5106.
113. Shibayama K., Wachino J., Arakawa Y., Saidijam M., Rutherford N.G., Henderson P.J.F. Metabolism of glutamine and glutathione via gamma-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: Possible significance in the pathophysiology of the organism. Molecular Microbiology 2007, 64:396-406.
114. Siitonen T., Alaruikka P., Mantymaa P., Savolainen E.R., Kavanagh T.J., Krejsa C.M., et al. Protection of acute myeloblastic leukemia cells against apoptotic cell death by high glutathione and gamma-glutamylcysteine synthetase levels during etoposide-induced oxidative stress. Annals of Oncology 1999, 10:1361-1367.
115. Slavens K.D., Brown T.R., Barakat K.A., Cundari T.R., Anderson M.E. Valine 44 and valine 45 of human glutathione synthetase are key for subunit stability and negative cooperativity. Biochemical and Biophysical Research Communications 2011, 410:597-601.
116. Snoke J.E., Bloch K. Studies on the mechanism of action of glutathione synthetase. The Journal of Biological Chemistry 1955, 213:825-835.
117. Sousa Silva M., Gomes R.A., Ferreira A.E., Ponces Freire A., Cordeiro C. The glyoxalase pathway: The first hundred years. . . and beyond. The Biochemical Journal 2013, 453:1-15.
118. Sporn M.B., Liby K.T. NRF2 and cancer: The good, the bad and the importance of context. Nature Reviews Cancer 2012, 12:564-571.
119. Stokke O., Marstein S., Jellum E., Lie S.O. Accumulation of pyroglutamic acid (5-oxoproline) in homocystinuria. Scandinavian Journal of Clinical and Laboratory Investigation 1982, 42:361-369.
120. Strasak A.M., Pfeiffer R.M., Klenk J., Hilbe W., Oberaigner W., Gregory M., et al. Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women. International Journal of Cancer 2008, 123:1902-1906.
121. Sullivan L.B., Martinez-Garcia E., Nguyen H., Mullen A.R., Dufour E., Sudarshan S., et al. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Molecular Cell 2013, 51:236-248.
122. Sun W.M., Huang Z.Z., Lu S.C. Regulation of gamma-glutamylcysteine synthetase by protein phosphorylation. The Biochemical Journal 1996, 320(Pt. 1):321-328.
123. Suzuki H., Kumagai H. Autocatalytic processing of gamma-glutamyltranspeptidase. The Journal of Biological Chemistry 2002, 277:43536-43543.
124. Suzuki S., Tanaka T., Poyurovsky M.V., Nagano H., Mayama T., Ohkubo S., et al. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:7461-7466.
125. Takemura K., Kawachi H., Eishi Y., Kitagaki K., Negi M., Kobayashi M., et al. Gamma-glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors. Human Pathology 2014, 45:331-341.
126. Tang F., Xie C., Huang D., Wu Y., Zeng M., Yi L., et al. Novel potential markers of nasopharyngeal carcinoma for diagnosis and therapy. Clinical Biochemistry 2011, 44:711-718.
127. Tattoli I., Sorbara M.T., Vuckovic D., Ling A., Soares F., Carneiro L.A., et al. Amino acid starvation induced by invasive bacterial pathogens triggers an innate host defense program. Cell Host & Microbe 2012, 11:563-575.
128. Thompson G.A., Meister A. Utilization of L-cystine by the gamma-glutamyl transpeptidase-gamma-glutamyl cyclotransferase pathway. Proceedings of the National Academy of Sciences of the United States of America 1975, 72:1985-1988.
129. Townsend D.M., Tew K.D. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003, 22:7369-7375.
130. Traverso N., Ricciarelli R., Nitti M., Marengo B., Furfaro A.L., Pronzato M.A., et al. Role of glutathione in cancer progression and chemoresistance. Oxidative Medicine and Cellular Longevity 2013, 2013:972913.
131. Tu Z., Anders M.W. Identification of an important cysteine residue in human glutamate-cysteine ligase catalytic subunit by site-directed mutagenesis. The Biochemical Journal 1998, 336(Pt. 3):675-680.
132. Uejima D., Nishijo K., Kajita Y., Ishibe T., Aoyama T., Kageyama S., et al. Involvement of cancer biomarker C7orf24 in the growth of human osteosarcoma. Anticancer Research 2011, 31:1297-1305.
133. Van Der Werf P., Griffith O.W., Meister A. 5-Oxo-L-prolinase (L-pyroglutamate hydrolase). Purification and catalytic properties. The Journal of Biological Chemistry 1975, 250:6686-6692.
134. Van der Werf P., Orlowski M., Meister A. Enzymatic conversion of 5-oxo-L-proline (L-pyrrolidone carboxylate) to L-glutamate coupled with cleavage of adenosine triphosphate to adenosine diphosphate, a reaction in the -glutamyl cycle. Proceedings of the National Academy of Sciences of the United States of America 1971, 68:2982-2985.
135. Van Der Werf P., Stephani R.A., Meister A. Accumulation of 5-oxoproline in mouse tissues after inhibition of 5-oxoprolinase and administration of amino acids: Evidence for function of the gamma-glutamyl cycle. Proceedings of the National Academy of Sciences of the United States of America 1974, 71:1026-1029.
136. Wang W., Ballatori N. Endogenous glutathione conjugates: Occurrence and biological functions. Pharmacological Reviews 1998, 50:335-356.
137. Watanabe T., Abe K., Ishikawa H., Iijima Y. Bovine 5-oxo-L-prolinase: Simple assay method, purification, cDNA cloning, and detection of mRNA in the coronary artery. Biological & Pharmaceutical Bulletin 2004, 27:288-294.
138. Wellner V.P., Sekura R., Meister A., Larsson A. Glutathione synthetase deficiency, an inborn error of metabolism involving the gamma-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proceedings of the National Academy of Sciences of the United States of America 1974, 71:2505-2509.
139. Welsch D.J., Creely D.P., Hauser S.D., Mathis K.J., Krivi G.G., Isakson P.C. Molecular cloning and expression of human leukotriene-C4 synthase. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:9745-9749.
140. West M.B., Chen Y., Wickham S., Heroux A., Cahill K., Hanigan M.H., et al. Novel insights into eukaryotic gamma-glutamyltranspeptidase 1 from the crystal structure of the glutamate-bound human enzyme. The Journal of Biological Chemistry 2013, 288:31902-31913.
141. Williamson J.M., Meister A. New substrates of 5-oxo-L-prolinase. The Journal of Biological Chemistry 1982, 257:12039-12042.
142. Willis M.N., Liu Y., Biterova E.I., Simpson M.A., Kim H., Lee J., et al. Enzymatic defects underlying hereditary glutamate cysteine ligase deficiency are mitigated by association of the catalytic and regulatory subunits. Biochemistry 2011, 50:6508-6517.
143. Winkler A., Njalsson R., Carlsson K., Elgadi A., Rozell B., Abraham L., et al. Glutathione is essential for early embryogenesis-Analysis of a glutathione synthetase knockout mouse. Biochemical and Biophysical Research Communications 2011, 412:121-126.
144. Yang Y., Dieter M.Z., Chen Y., Shertzer H.G., Nebert D.W., Dalton T.P. Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. The Journal of Biological Chemistry 2002, 277:49446-49452.
145. Yoshimoto T., Soberman R.J., Lewis R.A., Austen K.F. Isolation and characterization of leukotriene C4 synthetase of rat basophilic leukemia cells. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:8399-8403.
146. Zhang W., Braun A., Bauman Z., Olteanu H., Madzelan P., Banerjee R. Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines. Cancer Research 2005, 65:1554-1560.
147. Zhang W., Trachootham D., Liu J., Chen G., Pelicano H., Garcia-Prieto C., et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nature Cell Biology 2012, 14:276-286.